Company Comparison
Synthorx vs 54gene
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Synthorx | 54gene |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | — | Lagos, Nigeria |
| Founded | — | 2019 |
| Status | Active | Active |
| Last Funding Stage | — | Series B |
| Total Funding | — | $45M |
| Valuation | — | — |
What They Build
Synthorx
Biopharmaceutical company developing engineered protein therapeutics for cancer using expanded genetic code technology.
54gene
African genomics research company advancing precision medicine through genetic research focused on African populations.
Key Investors
Synthorx
Sector Overlap
Both Synthorx and 54gene operate in Biotech.
Browse all Biotech companies →Websites
Sponsored
AArchstone
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
LP portal & reportingCapital callsPortfolio tracking$297/moNo AUM fees
Now in alpha with select funds. 14-day trial available.